Showing results (1-10 of 60) with videos related to
Sort By:
Pageof 6
Drug Discovery Today. Technologies|September 21, 2013
Dualsteric GPCR targeting and functional selectivity: the paradigmatic M(2) muscarinic acetylcholine receptorAndreas Bock, Klaus MohrMolecular Pharmacology|September 15, 2005
Atypical muscarinic allosteric modulation: cooperativity between modulators and their atypical binding topology in muscarinic M2 and M2/M5 chimeric receptorsChristian Tränkle, Andreas Dittmann, Uwe Schulz, et al.International Journal of Environmental Research and Public Health|June 10, 2022
Effects of COVID-19 Restriction Policies on Urban Heat Islands in Some European Cities: Berlin, London, Paris, Madrid, and FrankfurtTaher Safarrad, Mostafa Ghadami, Andreas DittmannPharmazie in Unserer Zeit|October 25, 2007
[Angiogenesis inhibitors for vision loss. Ranibizumab for macular degeneration]Marion Mohr-Andrä, Klaus MohrNeuropharmacology|September 23, 2017
Allosteric modulators targeting CNS muscarinic receptorsAndreas Bock, Ramona Schrage, Klaus MohrNaunyn-Schmiedeberg'S Archives of Pharmacology|July 23, 2018
N-Ethylmaleimide differentiates between the M2- and M4-autoreceptor-mediated inhibition of acetylcholine release in the mouse brainJustine Etscheid, Klaus Mohr, Eberhard SchlickerPharmazie in Unserer Zeit|October 25, 2007
[Angiogenesis inhibitors in cancer therapy. Bevacizumab against colon carcinoma]Christian Fieth, Anna Kebig, Klaus MohrJournal of Molecular Neuroscience : MN|December 29, 2006
Allosteric modulators and selective agonists of muscarinic receptorsUlrike Holzgrabe, Marco De Amici, Klaus MohrArchiv Der Pharmazie|September 23, 2003
Contribution of lateral substituents in symmetrical and non-symmetrical heptane-bisammonio compounds to the allosteric stabilization of N-methylscopolamine binding to muscarinic M2 receptorsMarkus Staudt, Christian Tränkle, Klaus Mohr, et al.Journal of Medicinal Chemistry|March 18, 2005
Muscarinic allosteric enhancers of ligand binding: pivotal pharmacophoric elements in hexamethonio-type agentsMathias Muth, Matthias Sennwitz, Klaus Mohr, et al.Pageof 6